Drug Shortage Report for NOZINAN
| Report ID | 178933 |
| Drug Identification Number | 01927698 |
| Brand name | NOZINAN |
| Common or Proper name | NOZINAN INJ 25MG/ML |
| Company Name | NEURAXPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | METHOTRIMEPRAZINE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 |
| ATC code | N05AA |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-07-25 |
| Actual start date | 2022-07-18 |
| Estimated end date | Unknown |
| Actual end date | 2023-09-29 |
| Shortage status | Resolved |
| Updated date | 2023-09-30 |
| Company comments | The product will continue to be on allocation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ELISABETH-SELBERT-STR. 23 LANGENFELD, GERMANY 40764 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2023-09-30 | English | Compare |
| v17 | 2023-09-28 | French | Compare |
| v16 | 2023-09-28 | English | Compare |
| v15 | 2023-09-28 | English | Compare |
| v14 | 2023-06-02 | English | Compare |
| v13 | 2023-04-17 | English | Compare |
| v12 | 2023-01-03 | French | Compare |
| v11 | 2023-01-03 | English | Compare |
| v10 | 2023-01-03 | French | Compare |
| v9 | 2023-01-03 | English | Compare |
| v8 | 2022-12-20 | French | Compare |
| v7 | 2022-12-20 | English | Compare |
| v6 | 2022-12-20 | French | Compare |
| v5 | 2022-12-20 | English | Compare |
| v4 | 2022-12-20 | French | Compare |
| v3 | 2022-12-20 | English | Compare |
| v2 | 2022-12-20 | French | Compare |
| v1 | 2022-12-20 | English | Compare |
Showing 1 to 18 of 18